Clinical Trials & Their Trends in India
A couple of years back the Indian clinical research industry had witnessed turbulent times. The
chances of expecting India gaining importance for the global biopharmaceutical industry and the
advent of a competent innovation oriented local industry was offset by a downswing in the regulatory
environment and media news that reflected an unfavorable image of the industry. On the brighter side,
such challenges stimulated the industry into proactive action and acted as a catalyst for the industry,
regulatory authorities and other main stakeholders to join hands on a common platform to discuss on
concerns essential to the industry.
The pharmaceutical industry in Asia is expanding Indian pharmaceutical companies are estimated to
lead the region and significantly contribute to the expansion of the regional market for the contract
research by developing biosimilars, medical devices, therapeutic equivalents, Clinical Trial Phase I to IV
studies focusing on verticals such as clinical pharmacokinetic and bioavailability along with a growing
number of NBE’s and NCE’s. Such regional innovation efforts are underpinned by heavy investments
in the research and development during the past four to five years a few of which has already begun
to yield new chemical entities from the region. However, these companies are more likely to be in the
favor of home country as a location for clinical trial development initiatives.
India’s potential to become an innovation hub for clinical trials and medical studies depends on an
evolved medical research ecosystem and proactive attempts to address the medical loopholes. In this
regard, there needs to be attempted for safer and better healthcare in India that includes increasing
the level of competency of the Indian healthcare workforce, to make India an innovation hub and grow
the services revenue from India. In order to attain this objective, it is essential to have a holistic medical
plan created by the stakeholders comprising the academia, media, organization and industry bodies that
concentrates on a stronger regulatory framework that covers both policy and governance, professional
healthcare education. It also includes promoting a culture of innovation, a positive media environment
and efficient public awareness.
With India’s focus on the expansion in service industries that are based on knowledge oriented
businesses the widely available talent and government assistance, the clinical research industry
prospects are promising. Hence, one can be sure that the industry will keep on expanding aiming to
offer better health care services and making safeguarding patients their main objective.
Read More About: biometrics companies, regulatory services